ZOPPI, NICOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 5.110
EU - Europa 5.089
AS - Asia 2.486
SA - Sud America 411
AF - Africa 36
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 13.154
Nazione #
US - Stati Uniti d'America 5.040
PL - Polonia 2.705
CN - Cina 930
SG - Singapore 770
UA - Ucraina 528
IT - Italia 498
BR - Brasile 342
DE - Germania 335
GB - Regno Unito 305
HK - Hong Kong 291
FR - Francia 230
FI - Finlandia 169
VN - Vietnam 155
TR - Turchia 96
RU - Federazione Russa 91
IE - Irlanda 90
IN - India 75
CA - Canada 42
ID - Indonesia 37
NL - Olanda 32
BD - Bangladesh 29
AR - Argentina 25
BE - Belgio 25
MX - Messico 23
SE - Svezia 21
AT - Austria 18
KR - Corea 18
IQ - Iraq 16
AU - Australia 15
SA - Arabia Saudita 15
ZA - Sudafrica 12
ES - Italia 11
VE - Venezuela 10
TW - Taiwan 9
CZ - Repubblica Ceca 8
CL - Cile 7
JP - Giappone 7
PK - Pakistan 7
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
MU - Mauritius 5
PE - Perù 5
UY - Uruguay 5
UZ - Uzbekistan 5
CO - Colombia 4
EU - Europa 4
IL - Israele 4
LT - Lituania 4
MA - Marocco 4
TN - Tunisia 4
EG - Egitto 3
JO - Giordania 3
KE - Kenya 3
PT - Portogallo 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CH - Svizzera 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
TH - Thailandia 1
Totale 13.154
Città #
Warsaw 2.704
Fairfield 631
Woodbridge 517
Ashburn 473
Jacksonville 401
Singapore 369
Houston 362
Hong Kong 289
Cambridge 252
Seattle 249
Brescia 246
Wilmington 244
Beijing 216
Ann Arbor 207
Chandler 162
Princeton 161
Nanjing 137
Lancaster 135
New York 122
Dublin 90
Los Angeles 90
Helsinki 88
Dearborn 85
Dong Ket 80
Istanbul 75
Munich 62
Nanchang 46
The Dalles 42
Changsha 41
Des Moines 40
Shenyang 38
London 37
Buffalo 34
San Diego 34
Jinan 31
Milan 31
Jakarta 30
Redondo Beach 30
Hebei 29
São Paulo 29
Tianjin 29
Ho Chi Minh City 27
San Francisco 26
Chicago 25
Kunming 23
Rome 23
Shanghai 23
Dallas 20
Moscow 20
Turku 19
Brussels 18
Nuremberg 18
Phoenix 18
Jiaxing 17
Zhengzhou 17
Ningbo 16
Santa Clara 16
Hangzhou 15
Hanoi 14
Boardman 13
Rio de Janeiro 13
Taizhou 13
Toronto 13
Verona 13
Mexico City 11
Seongnam 11
Brooklyn 10
Guangzhou 10
Lanzhou 10
Atlanta 9
Falls Church 9
Porto Alegre 9
Vienna 9
Baghdad 8
Belo Horizonte 8
Chennai 8
Council Bluffs 8
Johannesburg 8
Manchester 8
Riyadh 8
Washington 8
Augusta 7
Dhaka 7
Fuzhou 7
Orem 7
Taipei 7
Turin 7
Auburn Hills 6
Boston 6
Haikou 6
Hamilton 6
Lappeenranta 6
Montreal 6
Mumbai 6
Norwalk 6
Ottawa 6
Poplar 6
Stockholm 6
Taiyuan 6
Waanrode 6
Totale 9.660
Nome #
Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome 344
Transcriptome-wide expression profiling in skin fibroblasts of patients with joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type 324
Bruch's membrane abnormalities in PRDM5-related brittle cornea syndrome 296
Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome 292
Arterial Tortuosity Syndrome: a vitamin C compartmentation disease? 277
GLUT10-Lacking in Arterial Tortuosity Syndrome-Is Localized to the Endoplasmic Reticulum of Human Fibroblasts 277
Insights in the etiopathology of galactosyltransferase II (GalT-II) deficiency from transcriptome-wide expression profiling of skin fibroblasts of two sisters with compound heterozygosity for two novel B3GALT6 mutations 271
Multifaced Roles of the αvβ3 Integrin in Ehlers–Danlos and Arterial Tortuosity Syndromes’ Dermal Fibroblasts 268
Glucose transporter type 10-lacking in arterial tortuosity syndrome-facilitates dehydroascorbic acid transport 266
Clinical and molecular characterization of 40 patients with classic Ehlers--Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations. 265
GLUT10 deficiency leads to oxidative stress and non-canonical αvβ3 integrin-mediated TGFβ signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts 265
The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations. 260
GLUT10 deficiency leads to oxidative stress and non-canonical avb3 integrin-mediated TGF signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts. 260
Characterization and expression of slc2a10, the zebrafish ortholog of the human gene involved in arterial tortuosity syndrome. 243
Diagnosis of vascular Ehlers-Danlos syndrome in Italy: clinical findings and novel COL3A1 mutations 241
A cellular test for Ehlers-Danlos syndromes diagnosis. 232
Molecular characterization and transcriptome-wide expression profiling of two patients affected with spondyloepimetaphyseal dysplasia with joint laxity type 229
Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients' skin fibroblasts 219
Classic Ehlers-danlos syndrome: clinical and molecular characterisation of 37 patients 218
Report on a patient with extremely fragile skin, dermatosparaxis, joint hypermobility, short stature, skeletal deformities, and lipomas: a new syndrome? 218
Type V and type III collagen modulate the expression and assembly of fibronectin extracellar matrix in classic and vascular Ehlers-Danlos syndrome fibroblasts, affecting cell survival and migration 213
Spectrum of mucocutaneous, ocular and facial features and delineation of novel presentations in 62 classical Ehlers-Danlos syndrome patients 194
Dystrophic epidermolysis bullosa pruriginosa in Italy: molecular characterization and pathogenesic aspects 193
Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant 175
Cellular and molecular mechanisms in the pathogenesis of classical, vascular, and hypermobile ehlers‒danlos syndromes 174
Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxia 173
Study of conformational properties of a biologically active peptide of Fibronectin by circular dichroism, NMR and molecular dynamics simulation 170
Adult presentation of arterial tortuosity syndrome in a 51-year-old woman with a novel homozygous c.1411+1G>A mutation in the SLC2A10 gene 164
Dermal fibroblast-to-myofibroblast transition sustained by αvβ3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders 164
Wound repair capability in EDS fibroblasts can be retrieved by exogenous type V collagen 164
Angiokeratoma Corporis Diffusum and arteriovenous fistulas with dominant transmission in the absence of metabolic disorders. 163
Three homozygous PTC mutations in the collagen type VII gene of patients affected by recessive dystrophic epidermolysis bullosa: analysis of transcript levels in dermal fibroblasts 162
Cytogenetic and molecular characterization of a de-novo t(2p;7p) translocation involving TNS3 and EXOC6B genes in a boy with a complex syndromic phenotype 162
COL6A5 variants in familial neuropathic chronic itch 149
Characterization and expression pattern analysis of the facilitative glucose transporter 10 gene (slc2a10) in Danio rerio 145
Transcriptome-wide expression profiling in skin fibroblasts of patients with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type 145
Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-β 143
Recurrence of the p.R156X TNNI2 mutation in distal arthrogryposis type 2B 142
Type III and V collagens modulate the expression and assembly of EDA+ fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts 142
Biological insights in the pathogenesis of hypermobile Ehlers-Danlos syndrome from proteome profiling of patients' dermal myofibroblasts 141
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 139
Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss 133
L’integrina avb3 inibisce il potenziale invasivo e metastatico di cellule tumorali umane esprimenti stabilmente il peptide FN13, attraverso la disattivazione di ILK. 132
Characterization of a 13 aminoacid human fibronectin peptide induce matrix assembly and inhibiting migration and invasion in tumor cells 131
A -96C-T mutation in the promoter of the collagen type VII gene (COL7A1) abolishing transcription in a patient affected by recessive dystrophic epidermolys bullosa 130
Diagnosis of vascular Ehlers-Danlos syndrome in Italy: clinical findings and novel COL3A1 mutations. 128
Caratterizzazione ed espressione di slc2a10, l’ortologo in Danio rerio del gene umano coinvolto nella sindrome delle arterie tortuose. 125
Altered fibronectin RNA splicing in skin fibroblasts from Ehlers-Danlos syndrome patients: in situ hybridization analysis. 124
Rescue of migratory defects of Ehlers-Danlos syndrome fibroblasts in vitro by type V collagen but not insulin-like binding protein-1. 124
TAB2 c.1398dup variant leads to haploinsufficiency and impairs extracellular matrix homeostasis 124
Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide 123
Genotype-phenotype correlation in Italian patients with epidermolysis bullosa dystrophica 122
Exclusion of candidate genes in a family with arterial tortuosity syndrome 122
Dystrophic epidermolysis bullosa pruriginosa in Italy: clinical and molecular characterization 121
Dexamethasone-induced healing of chronic leg ulcers in a patient with defective organization of the extracellular matrix of fibronectin. 120
Mutations in PRDM5 in brittle cornea syndrome identify a pathway regulating extracellular matrix development and maintenance. 120
Correction of the defective extracellular matrix of Ehlers-Danlos syndrome skin fibroblasts by dexamethasone. 119
Angiocheratomas and arterovenous fistulas with dominant trasmission in the absence of metabolic disorders. 118
The novel p.G150R missense mutation in the cartilage matrix protein subdomain of type VII collagen in compound heterozigosity with the c.682+1G>A COL7A1 splicing mutation leads to mild dystrophic epidermolysis bullosa 117
Effect of dexamethasone on the assembly of the matrix of fibronectin and its receptors organization in Ehlers-Danlos syndrome skin fibroblasts. 113
Loeys-Dietz syndrome type I and type II: clinical findings and novel mutations in two Italian patients 112
Compound heterozygosity for a novel and a recurrent ABCC6 gene mutation in an Italian family with pseudoxanthoma elasticum 112
Alternative splicing of mGluR6 gene generates a truncated glutamate receptor in rat retina. 111
Modulation of the facilitative glucose transporters (SLC2A) gene family expression in arterial tortuosity syndrome skin fibroblasts and aortic vascular smooth muscle cells. 108
COL1-related overlap disorder: a novel connective tissue disorder incorporating the osteogenesis imperfecta/Ehlers-Danlos syndrome overlap 105
Quantitative in situ hybridization for the evaluation of cell – cycle related gene expression. 104
Identification of two splicing mutations in the collagen type VII gene (COL7A1) of a patient affected by the localisata variant of recessive dystrophic epidermolysis bullosa 104
Different phenotypes in recessive dystrophic epidermolysis bullosa patients sharing the same mutation in compound heterozygosity with two novel mutations in COL7A1. 98
Two novel SLC2A10/GLUT10 mutations in a patient with arterial tortuosity sindrome 95
Congenital myopathy Ehlers-Danlos overlap syndrome caused by the deficiency of an enzyme involved in protein folding in the endoplasmic reticulum: identification and characterization of a novel disorder. 95
BIOLOGIA E GENETICA DEL MUSCOLO 93
Quantitative evaluation of mRNAs by in situ hybridization and image analysis: principles and applications. 87
Genetic heterogeneity in the Brittle Cornea Syndrome (BCS) –New evidences that ZNF469 and PRDM5 regulate extracellular matrix development and maintenance within the same pathway 86
Insights into the molecular pathogenesis of cardiospondylocarpofacial syndrome: MAP3K7 c.737-7A>G variant alters the TGFβ-mediated α-SMA cytoskeleton assembly and autophagy 84
Quantitative in situ hybridization for the evaluation of gene expression in asynchronous and synchronized cell cultures and in tissue sections 80
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 79
Deciphering disease signatures and molecular targets in vascular Ehlers-Danlos syndrome through transcriptome and miRNome sequencing of dermal fibroblasts 79
L’organizzazione della matrice di collagene III nei fibroblasti dermici regola l’espressione di geni coinvolti nell’elastogenesi. 78
In search of the SLC2A10 gene role in the etiopathogenesis of arterial tortuosity syndrome by transcriptomic and biochemical approaches 76
The FN13 peptide inhibits human tumor cells invasion through the modulation of alphavbeta3 integrins organization and the inactivation of ILK pathway 72
Il collagene III ripristina la migrazione e il riparo delle ferite in vitro in fibroblasti di pazienti affetti da Sindrome di Ehlers-Danlos vascolare. 70
FAK-independent alphavbeta3 integrin-EGFR complexes rescue from anoikis matrix-defective fibroblasts 69
Integrative Multi-Omics Approach in Vascular Ehlers–Danlos Syndrome: Further Insights into the Disease Mechanisms by Proteomic Analysis of Patient Dermal Fibroblasts 65
Human fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate alpha2beta1 integrin and recruit alphavbeta3 instead of alpha5beta1 integrin 65
Collageni purificati inducono in fibroblasti umani difettivi la sintesi di fibronectina EDA+ e la sua organizzazione nella matrice extracellulare. 64
null 49
Matrix metalloproteinases inhibition by doxycycline rescues extracellular matrix organization and partly reverts myofibroblast differentiation in hypermobile ehlers-danlos syndrome dermal fibroblasts: A potential therapeutic target? 48
RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms 46
Truncating variants in the penultimate exon of TGFBR1 escaping nonsense-mediated mRNA decay cause Loeys-Dietz syndrome 45
Loeys- Dietz Sindrome and Vascular Ehlers- Danlos Sindrome: differential diagnosis by clinical and molecular approaches 35
Totale 13.442
Categoria #
all - tutte 55.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.082 0 0 0 0 0 185 92 177 220 144 144 120
2021/2022789 46 169 21 18 21 38 47 45 60 82 66 176
2022/2023563 101 9 11 35 34 164 11 55 75 12 22 34
2023/2024720 41 15 45 64 47 150 42 15 155 27 18 101
2024/20251.553 14 8 20 236 156 133 164 48 166 66 327 215
2025/20261.662 300 398 216 394 299 55 0 0 0 0 0 0
Totale 13.442